189 related articles for article (PubMed ID: 30546365)
21. NK cells and exercise: implications for cancer immunotherapy and survivorship.
Bigley AB; Simpson RJ
Discov Med; 2015 Jun; 19(107):433-45. PubMed ID: 26175401
[TBL] [Abstract][Full Text] [Related]
22. Ly-6C+ natural T (NT) cells mediate immune surveillance against NK-sensitive and NK-resistant transplantable tumours in certain strains of mice.
Martiniello R; Burton RC; Smart YC
Int J Cancer; 1996 May; 66(4):532-7. PubMed ID: 8635870
[TBL] [Abstract][Full Text] [Related]
23. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cell-mediated immunosurveillance of human cancer.
Malmberg KJ; Carlsten M; Björklund A; Sohlberg E; Bryceson YT; Ljunggren HG
Semin Immunol; 2017 Jun; 31():20-29. PubMed ID: 28888619
[TBL] [Abstract][Full Text] [Related]
25. Antitumor cells found in tumor-bearing mice given ubenimex.
Ishizuka M; Masuda T; Mizutani S; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1987 May; 40(5):697-701. PubMed ID: 3497141
[TBL] [Abstract][Full Text] [Related]
26. Lack of correlation between natural killer activity and tumor growth control in nude mice with different immune defects.
Fodstad O; Hansen CT; Cannon GB; Statham CN; Lichtenstein GR; Boyd MR
Cancer Res; 1984 Oct; 44(10):4403-8. PubMed ID: 6467201
[TBL] [Abstract][Full Text] [Related]
27. The Inhibitory NKR-P1B:Clr-b Recognition Axis Facilitates Detection of Oncogenic Transformation and Cancer Immunosurveillance.
Tanaka M; Fine JH; Kirkham CL; Aguilar OA; Belcheva A; Martin A; Ketela T; Moffat J; Allan DSJ; Carlyle JR
Cancer Res; 2018 Jul; 78(13):3589-3603. PubMed ID: 29691253
[TBL] [Abstract][Full Text] [Related]
28. Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.
Chen WF; Lau WS; Cheung PY; Guo DA; Wong MS
Br J Pharmacol; 2006 Mar; 147(5):542-51. PubMed ID: 16415910
[TBL] [Abstract][Full Text] [Related]
29. Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-γ and induces NK cell-dependent lymphoma control without other immunotherapies.
Pötzl J; Roser D; Bankel L; Hömberg N; Geishauser A; Brenner CD; Weigand M; Röcken M; Mocikat R
Int J Cancer; 2017 May; 140(9):2125-2133. PubMed ID: 28195314
[TBL] [Abstract][Full Text] [Related]
30. Cancer immunosurveillance: NKG2D breaks cover.
Ljunggren HG
Immunity; 2008 Apr; 28(4):492-4. PubMed ID: 18400193
[TBL] [Abstract][Full Text] [Related]
31. Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice.
Stutman O; Cuttito MJ
Nature; 1981 Mar; 290(5803):254-7. PubMed ID: 7207617
[TBL] [Abstract][Full Text] [Related]
32. Hybrid resistance to EL-4 lymphoma cells. II. Association between loss of hybrid resistance and detection of suppressor cells after treatment of mice with 89Sr.
Leuvano E; Kumar V; Bennett M
Scand J Immunol; 1981; 13(6):563-71. PubMed ID: 6458878
[TBL] [Abstract][Full Text] [Related]
33. [Natural killer (NK) cell and immunotherapy].
Iino T; Takaishi S
Nihon Rinsho; 2017 Feb; 75(2):306-311. PubMed ID: 30562869
[TBL] [Abstract][Full Text] [Related]
34. Natural killer (NK) cell activity in mice with acute graft-versus-host reactions: characterization of a Thy-1+ NK-like cell with a broadened spectrum of lytic activity in the spleen and lymph nodes.
MacDonald GC; Gartner JG
Scand J Immunol; 1991 May; 33(5):553-65. PubMed ID: 1709518
[TBL] [Abstract][Full Text] [Related]
35. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
Chow DA; Wolosin LB; Greenberg AH
J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
[TBL] [Abstract][Full Text] [Related]
36. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
Guo SW; Du Y; Liu X
Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
[TBL] [Abstract][Full Text] [Related]
37. NK-Cell-Encapsulated Porous Microspheres via Microfluidic Electrospray for Tumor Immunotherapy.
Wu D; Yu Y; Zhao C; Shou X; Piao Y; Zhao X; Zhao Y; Wang S
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33716-33724. PubMed ID: 31454227
[TBL] [Abstract][Full Text] [Related]
38. Cancer immunosurveillance and immunoediting by natural killer cells.
Gross E; Sunwoo JB; Bui JD
Cancer J; 2013; 19(6):483-9. PubMed ID: 24270347
[TBL] [Abstract][Full Text] [Related]
39. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
[TBL] [Abstract][Full Text] [Related]
40. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
